Ashfield Capital Partners, LLC Amgen Inc Transaction History

Ashfield Capital Partners, LLC

$1.19 Billion
Q3 2022

A detailed history of Ashfield Capital Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ashfield Capital Partners, LLC holds 55,789 shares of AMGN stock, worth $17.8 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

55,789

Previous 56,023 0.42%

Holding current value

$17.8 Million

Previous $13.6 Million 7.74%

% of portfolio

1.06%

Previous 1.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $52,523 - $59,237	-234 Reduced 0.42%	55,789 $12.6 Million
Q2 2022 Jul 29, 2022	SELL	$230.71 - $256.74 $21,686 - $24,133	-94 Reduced 0.17%	56,023 $13.6 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $160,286 - $177,318	-731 Reduced 1.29%	56,117 $13.6 Million
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $87,904 - $100,599	-442 Reduced 0.77%	56,848 $12.8 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $80,238 - $94,008	-378 Reduced 0.66%	57,290 $12.2 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $218,163 - $242,036	-934 Reduced 1.59%	57,668 $14.1 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $325,763 - $379,624	-1,468 Reduced 2.44%	58,602 $14.6 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $80,709 - $96,110	373 Added 0.62%	60,070 $13.8 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $159,796 - $177,706	-681 Reduced 1.13%	59,697 $15.2 Million
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $83,871 - $102,921	-424 Reduced 0.7%	60,378 $14.2 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $109,526 - $145,261	601 Added 1.0%	60,802 $12.3 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $162,720 - $209,152	860 Added 1.45%	60,201 $14.5 Million
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $89,492 - $107,230	514 Added 0.87%	59,341 $11.5 Million
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $210,042 - $246,216	-1,260 Reduced 2.1%	58,827 $10.8 Million
Q1 2019 Apr 30, 2019	BUY	$180.87 - $203.88 $116,118 - $130,890	642 Added 1.08%	60,087 $11.4 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $475,079 - $554,569	2,663 Added 4.69%	59,445 $11.6 Million
Q3 2018 Nov 02, 2018	SELL	$185.29 - $208.89 $204,745 - $230,823	-1,105 Reduced 1.91%	56,782 $11.8 Million
Q2 2018 Jul 26, 2018	SELL	$166.05 - $186.51 $127,858 - $143,612	-770 Reduced 1.31%	57,887 $10.7 Million
Q1 2018 May 02, 2018	SELL	$169.43 - $198.0 $145,201 - $169,686	-857 Reduced 1.44%	58,657 $10 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $275,971 - $308,344	-1,635 Reduced 2.67%	59,514 $10.3 Million
Q3 2017 Nov 07, 2017	SELL	$167.29 - $191.0 $215,134 - $245,626	-1,286 Reduced 2.06%	61,149 $11.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	62,435	62,435 $10.8 Million

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashfield Capital Partners, LLC with notifications on news.

Account

Ashfield Capital Partners, LLC Amgen Inc Transaction History